These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38908995)

  • 21. Gastric Hyperplastic Polyps Can Shrink After Discontinuation of Proton Pump Inhibitors: A Case Series Compared With Continuation of Proton Pump Inhibitors.
    Nikaido M; Miyamoto S; Utsumi T; Shimizu T; Nakanishi Y; Kumagai K; Teramura M; Setoyama T; Seno H
    J Clin Gastroenterol; 2022 Mar; 56(3):e216-e221. PubMed ID: 34107516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
    Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
    Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease.
    Andreasson A; Agréus L; Mastellos N; Bliźniuk G; Waśko-Czopnik D; Angelaki A; Theodosaki E; Lionis C; Hek K; Verheij R; Wright E; Durbaba S; Muris J; Bródka P; Saganowski S; Ethiér JF; Curcin V; Delaney B
    Ann Med; 2024 Dec; 56(1):2354683. PubMed ID: 38753973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing the Inappropriate Use of Proton Pump Inhibitors in an Internal Medicine Residency Clinic.
    Boster J; Lowry LE; Bezzant ML; Kuiper B; Surry L
    Cureus; 2020 Jan; 12(1):e6609. PubMed ID: 32064190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescribing Patterns of Proton Pump Inhibitors in Germany: A Retrospective Study Including 472 146 Patients.
    Plehhova K; Haering M; Wray J; Coyle C; Ibáñez E; Kostev K
    J Prim Care Community Health; 2023; 14():21501319231221002. PubMed ID: 38142444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey.
    Kurlander JE; Rubenstein JH; Richardson CR; Krein SL; De Vries R; Zikmund-Fisher BJ; Yang YX; Laine L; Weissman A; Saini SD
    Am J Gastroenterol; 2020 May; 115(5):689-696. PubMed ID: 32091419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inappropriate proton-pump inhibitor prescribing in primary care - an observational study with quality circles.
    Vidonscky Lüthold R; Henz NC; Fuhrer C; Häner A; Schenk M; Jungo KT; Streit S
    Swiss Med Wkly; 2023 Sep; 153():40119. PubMed ID: 37769322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study.
    Trad KS; Simoni G; Barnes WE; Shughoury AB; Raza M; Heise JA; Turgeon DG; Fox MA; Mavrelis PG
    BMC Gastroenterol; 2014 Oct; 14():174. PubMed ID: 25284142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of clinical pharmacists' recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice.
    Bundeff AW; Zaiken K
    J Manag Care Pharm; 2013 May; 19(4):325-33. PubMed ID: 23627578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescribing Pattern of Proton Pump Inhibitors in Qatar Rehabilitation Institute: A Retrospective Study.
    Madi L; Ahmed Elhada AH; Alrawashdeh H; Ahmed A
    J Res Pharm Pract; 2019; 8(2):101-104. PubMed ID: 31367645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nissen fundoplication
    Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
    World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial.
    Yadlapati R; Masihi M; Gyawali CP; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE
    Gastroenterology; 2021 Jan; 160(1):174-182.e1. PubMed ID: 32949568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful deprescribing of unnecessary proton pump inhibitors in a primary care clinic.
    Odenthal DR; Philbrick AM; Harris IM
    J Am Pharm Assoc (2003); 2020; 60(1):100-104. PubMed ID: 31601478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of endoluminal gastroplication in Japanese patients with proton pump inhibitor-resistant, non-erosive esophagitis.
    Tokudome K; Funaki Y; Sasaki M; Izawa S; Tamura Y; Iida A; Ogasawara N; Konagaya T; Tokura Y; Kasugai K
    World J Gastroenterol; 2012 Nov; 18(41):5940-7. PubMed ID: 23139611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic management of uncomplicated gastroesophageal reflux disease in france in 2005: Potential cost savings of omeprazole substitution.
    Mouly S; Charlemagne A; Lejeunne P; Fagnani F
    Curr Ther Res Clin Exp; 2009 Aug; 70(4):282-98. PubMed ID: 24683238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients' perspectives on a patient-oriented electronic decision support tool to reduce overuse of proton pump inhibitors (arriba-PPI): a qualitative study in primary care.
    Schmidt A; Bücker B; Maas M; Löscher S; Becker A; Viniol A; Heisig J; Wilm S; Barzel A
    BMC Prim Care; 2023 Jan; 24(1):33. PubMed ID: 36698061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes From a Pharmacist - led Proton Pump Inhibitor Stewardship Program at a Single Institution.
    Wahking RA; Steele RL; Hanners RE; Lockwood SM; Davis KW
    Hosp Pharm; 2018 Feb; 53(1):59-67. PubMed ID: 29434389
    [No Abstract]   [Full Text] [Related]  

  • 40. Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment-Are PPIs Addictive?
    Namikawa K; Björnsson ES
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.